Beth Hayes, Consultant to Pharmaceutical Companies

In this episode of the Frictionless Supply Chain, Beth Hayes, a consultant to pharmaceutical companies, joins host Rosemary Coates, executive director of the Reshoring Institute, to discuss the complexity of pharmaceutical supply chains.

Pharmaceuticals and other medical products require unique compliance with FDA regulations and control. This complexity sets this industry’s supply chains apart from most others.

From individualized treatments to massive production of building block chemicals, the manufacturing of these products is global, often sourced from China and India. The risks of these long global supply chains and America’s dependence on imports were fully exposed during the pandemic. This resulted in new regulations, massive funding opportunities, and the reshoring of production.

Hayes has spent over 15 years navigating the intersection of life sciences and technology, with a career that spans biopharma leaders like Pfizer, tech giants like Salesforce, and top-tier consultancies like Accenture and KPMG. Currently, she consults to biopharma and related segments helping to modernize their businesses and evolve through AI-driven transformation

Beth Hayes can be contacted on LinkedIn.  You can reach out to the Reshoring Institute at www.Reshoringinstitute.org for more information on this important topic.